Literature DB >> 8490540

Effectiveness of colorectal cancer screening: results from a population-based case-control evaluation in Saarland, Germany.

J Wahrendorf1, B P Robra, H Wiebelt, R Oberhausen, M Weiland, G Dhom.   

Abstract

In order to evaluate the effectiveness of colorectal cancer screening by the faecal occult blood test (FOBT) in Germany a population-based case-control study was conducted in Saarland, a southwestern state of Germany. As cases, we identified 522 persons (244 males, 278 females) who died of colorectal cancer between 1983 and 1986 between the ages of 55 and 75 years. For 163 male cases complete screening histories were retrieved together with up to five age-matched controls who had not died of colorectal cancer identified from the files of the case's referring general practitioner (GP). For 209 female cases screening histories were retrieved from their GPs and gynaecologists as well as for age-matched controls. Individual screening histories were established with emphasis on identifying whether FOBTs were carried out asymptomatically or symptomatically. In the time period 6-36 months prior to diagnosis 13% of the male cases and 14% of the male controls had at least one asymptomatic FOBT with a corresponding matched odds ratio of 0.92 (95% CI: 0.61, 1.75). For the same prediagnostic period 16% of the female cases and 29% of the female controls had at least one asymptomatic FOBT leading to an odds ratio of 0.43 (95% CI: 0.27, 0.68). Thus, for males where participation rates are generally low, no protective effect could be seen but for females where participation rates are higher a clear protective effect is seen. Possibilities for bias need to be taken into consideration when interpreting these results. Organizational measures ensuring a high penetrance of a mass screening programme are seen as a way to elevate efficacy.

Entities:  

Mesh:

Year:  1993        PMID: 8490540

Source DB:  PubMed          Journal:  Eur J Cancer Prev        ISSN: 0959-8278            Impact factor:   2.497


  15 in total

1.  Effect of faecal occult blood screening on mortality from colorectal cancer: results from a randomised controlled trial.

Authors:  J H Scholefield; S Moss; F Sufi; C M Mangham; J D Hardcastle
Journal:  Gut       Date:  2002-06       Impact factor: 23.059

Review 2.  Antagonist: population based endoscopic screening for colorectal cancer.

Authors:  D A L Macafee; J H Scholefield
Journal:  Gut       Date:  2003-03       Impact factor: 23.059

Review 3.  Screening for colorectal cancer using the faecal occult blood test, Hemoccult.

Authors:  P Hewitson; P Glasziou; L Irwig; B Towler; E Watson
Journal:  Cochrane Database Syst Rev       Date:  2007-01-24

4.  Comparison of three faecal occult blood tests in the detection of colorectal neoplasia.

Authors:  R L Hope; G Chu; A H Hope; R G Newcombe; P E Gillespie; S J Williams
Journal:  Gut       Date:  1996-11       Impact factor: 23.059

Review 5.  The impact of screening on colorectal cancer mortality and incidence: has it really made a difference?

Authors:  Ann G Zauber
Journal:  Dig Dis Sci       Date:  2015-03-05       Impact factor: 3.199

6.  The risks of screening: data from the Nottingham randomised controlled trial of faecal occult blood screening for colorectal cancer.

Authors:  M H Robinson; J D Hardcastle; S M Moss; S S Amar; J O Chamberlain; N C Armitage; J H Scholefield; C M Mangham
Journal:  Gut       Date:  1999-10       Impact factor: 23.059

7.  Prevention of colorectal cancer: guidelines based on new data. WHO Collaborating Center for the Prevention of Colorectal Cancer.

Authors:  S J Winawer; D J St John; J H Bond; P Rozen; R W Burt; J D Waye; O Kronborg; M J O'Brien; D T Bishop; R C Kurtz
Journal:  Bull World Health Organ       Date:  1995       Impact factor: 9.408

8.  Colorectal cancer screening in asymptomatic populations.

Authors:  A R Hart; A C Wicks; J F Mayberry
Journal:  Gut       Date:  1995-04       Impact factor: 23.059

9.  Immunochemical vs guaiac faecal occult blood tests in a population-based screening programme for colorectal cancer.

Authors:  G Castiglione; M Zappa; G Grazzini; A Mazzotta; M Biagini; P Salvadori; S Ciatto
Journal:  Br J Cancer       Date:  1996-07       Impact factor: 7.640

10.  Long-lasting reduction of risk of colorectal cancer following screening endoscopy.

Authors:  H Brenner; V Arndt; T Stürmer; C Stegmaier; H Ziegler; G Dhom
Journal:  Br J Cancer       Date:  2001-09-28       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.